Boundless Bio, Inc. financial data

Symbol
BOLD on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1533% % 1.2%
Debt-to-equity 43% %
Return On Equity -48% % 85%
Return On Assets -33% % 17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,385,611 shares 0.38%
Common Stock, Shares, Outstanding 22,386,000 shares 0.59%
Entity Public Float $68,400,000 USD
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 22,386,000 shares 0.59%
Weighted Average Number of Shares Outstanding, Diluted 22,386,000 shares 0.59%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $48,343,000 USD -7.7%
General and Administrative Expense $19,485,000 USD 19%
Operating Income (Loss) $67,828,000 USD 1.4%
Nonoperating Income (Expense) $6,068,000 USD -21%
Net Income (Loss) Attributable to Parent $61,760,000 USD -1.1%
Earnings Per Share, Basic 7 USD/shares 16%
Earnings Per Share, Diluted 7 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $14,980,000 USD -63%
Cash, Cash Equivalents, and Short-term Investments $117,600,000 USD -30%
Assets, Current $120,156,000 USD -30%
Property, Plant and Equipment, Net $3,499,000 USD -12%
Operating Lease, Right-of-Use Asset $44,480,000 USD 40707%
Assets $168,721,000 USD -3.6%
Accounts Payable, Current $1,136,000 USD -55%
Employee-related Liabilities, Current $2,020,000 USD -29%
Liabilities, Current $11,845,000 USD 18%
Operating Lease, Liability, Noncurrent $46,707,000 USD
Liabilities $58,552,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000 USD -79%
Retained Earnings (Accumulated Deficit) $246,784,000 USD -33%
Stockholders' Equity Attributable to Parent $110,169,000 USD -33%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $110,169,000 USD -33%
Liabilities and Equity $168,721,000 USD -3.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,530,000 USD 7.9%
Net Cash Provided by (Used in) Financing Activities $924,000 USD -3081%
Net Cash Provided by (Used in) Investing Activities $3,060,000 USD -83%
Common Stock, Shares Authorized 700,000,000 shares 0%
Common Stock, Shares, Issued 22,386,000 shares 0.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11,470,000 USD -898%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,540,000 USD -62%
Deferred Tax Assets, Valuation Allowance $58,844,000 USD 54%
Deferred Tax Assets, Gross $72,102,000 USD 85%
Depreciation $263,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $59,000 USD -29%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $61,946,000 USD -2%
Property, Plant and Equipment, Gross $8,150,000 USD 9%
Operating Lease, Liability, Current $3,052,000 USD 2422%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Tax Assets, Operating Loss Carryforwards $27,618,000 USD 51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 70,000,000 shares 0%
Unrecognized Tax Benefits $9,212,000 USD 14%
Operating Lease, Payments $100,000 USD -86%
Additional Paid in Capital $356,901,000 USD 2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $317,000 USD 21%
Deferred Tax Assets, Net of Valuation Allowance $13,258,000 USD 1844%
Share-based Payment Arrangement, Expense $6,801,000 USD 6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%